Antibodies vs. Single SOMAmer™ Reagents in Affinity Assays

Researchers have long used antibodies for affinity assays, but they face challenges like batch variability, limited target access, and ethical concerns from animal use.

As the need for reliable, scalable solutions grows, scientists are turning to Single SOMAmer™ Reagents (SSRs). These fully synthetic, stable reagents can bind hidden or hard-to-reach protein targets that antibodies often miss. With nearly 11,000 available reagents and no animal involvement, SSRs offer consistency, faster turnaround, and broader protein access to advance research efficiently.

Download this infographic to learn more about:

• Structural and binding differences between antibodies and SSRs
• How SSRs reduce nonspecific binding and improve reproducibility
• Why SSRs offer faster, scalable, and more ethical solutions
• The growing availability of SSRs for hard-to-reach or rare protein targets